In the Singaporean pharmaceutical industry, there were 8 M&A deals announced in Q2 2023, worth a total value of $58.5m, according to GlobalData’s Deals Database. The $40m acquisition of bmx holdco by suzhou basecare medical was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, M&A activity in Singapore increased by 786% in Q2 2023 compared with the previous quarter’s total of $6.6m and fell by 83% as compared to Q2 2022. Related deal volume increased by 100% in Q2 2023 versus the previous quarter and was 300% higher than in Q2 2022.
For further understanding of GlobalData's Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.